Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Completed · Phase 3 · Has a placebo group

Conditions studied: Post-ERCP Acute Pancreatitis

In brief

Post-ERCP pancreatitis is a well-known and sometimes life-threatening complication of ERCP. Both LR and rectal indomethacin have shown benefit in preventing post-ERCP pancreatitis. Despite this, no study to date has evaluated both of these measures for preventing post-ERCP pancreatitis. It is our hope to evaluate the combination of these two modalities for preventing post-ERCP pancreatitis compared with either modality alone.

Key facts

Study ID
NCT02641561
Run by
The Cooper Health System
People needed
192
Starts
2014-10-01
Expected to finish
2016-06-01
Last updated by the study team
2018-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.